Johnson & Johnson wins FDA panel backing for a second dose of its COVID shot but don’t call it a ‘booster’
TrustVaccines
via FiercePharma: Vaccines https://ift.tt/2zKtXvv
October 15, 2021 at 03:59PM
Johnson & Johnson wins FDA panel backing for a second dose of its COVID shot but don’t call it a ‘booster’
Welcome to vaccine education 